NETFLIX TO ACQUIRE WARNER BROS. FOLLOWING THE SEPARATION OF DISCOVERY GLOBAL FOR A TOTAL ENTERPRISE VALUE OF $82.7 BILLION (Equity Value of $72.0 Billion)
Transaction Unites Warner Bros.' Iconic Franchises and Storied Libraries with Netflix's Leading Entertainment…
Signing Day Sports Shareholder Letter Details AI/HPC Infrastructure Opportunity with BlockchAIn Digital Infrastructure
SCOTTSDALE, AZ, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc.…
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
November 26, 2025 19:00 ET | Source: HUTCHMED (China) Limited HONG KONG…
FP Markets Wins Global Broker of the Year at the Finance Magnates Awards 2025
SYDNEY, Nov. 11, 2025 /PRNewswire/ -- FP Markets has been recognised with three prestigious…
Armada Acquisition Corp. II Announces Ticker Symbol to Change to XRPN on Oct 30, 2025
New ticker aligns with new $1 billion strategy for XRP exposure on…
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT…
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal…
XED Welcomes Back Technology Visionary Mrinal Srivastava as Chief Technology Officer
NEW YORK and MUMBAI, India, Sept. 26, 2025 /PRNewswire/ -- XED is proud…
IndoSpace expands presence with new 66-Acre Park in Maharashtra’s industrial and warehousing hub, Bhiwandi
MUMBAI, India, Sept. 26, 2025 /PRNewswire/ -- IndoSpace, India's fully integrated supply chain…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…